Rifampin labels and packages

Revision as of 23:57, 5 January 2014 by Chetan Lokhande (talk | contribs)
Jump to navigation Jump to search
Rifampin
FDA Package Insert (Rifadin®)
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

==Labels And Packages==

PRINCIPAL DISPLAY PANEL - 150mg Bottle Label

NDC 0068-0510-30 Rifadin® 150mg rifampin capsules USP 30 Capsules sanofi aventis


PRINCIPAL DISPLAY PANEL - 600mg Vial Carton

NDC 0068-0597-01 Rifadin® IV rifampin for injection USP 600mg For IV Infusion Only 1 Sterile Vial sanofi aventis [1]



References

  1. "RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC]".

Adapted from the FDA Package Insert.